ω‐Oxidation of Lipoxin B4 by Rat Liver: Identification of an ω‐Carboxy Metabolite of Lipoxin B4

Yoichi Mizukami, Hideki Sumimoto, Ryuichi Isobe, Shigeki Minakami, Koichiro Takeshige

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Lipoxin B4 (LXB4) is metabolized to 20‐hydroxy‐LXB4 by rat liver microsomes. The ω‐hydroxylation requires both molecular oxygen and NADPH, and is inhibited by carbon monoxide, indicating involvement of a cytochrome P‐450 (P‐450). This is supported by inhibition of the reaction by antibodies raised against NADPH–P‐450 reductase. The P‐450 appears to be the one responsible for leukotriene B4ω‐hydroxylation, because leukotriene B4 inhibits the formation of 20‐hydroxy‐LXB4 and LXB4 blocks the leukotriene B4ω‐hydroxylase activity in microsomes. Incubation of 20‐hydroxy‐LXB4 with both rat liver cytosol and NAD+ leads to formation of a more polar metabolite on high‐performance liquid chromatography. The metabolite is identified as 20‐carboxy‐LXB4, a novel metabolite of LXB4, based on analyses by ultraviolet spectrometry and by gas chromatography/mass spectrometry. The 20‐carboxy‐LXB4‐forming activity is localized in cytosol, with an optimal pH of 8.5. The activity is dependent on NAD+, but NADP+ can not replace NAD+. The reaction is inhibited by pyrazole and 4‐methylpyrazole, inhibitors of alcohol dehydrogenase, and by substrates of the enzyme such as ethanol and 20‐hydroxy‐leukotriene B4. Disulfiram, an inhibitor of aldehyde dehydrogenase, also blocks the 20‐carboxy‐LXB4 formation. These observations suggest that both alcohol dehydrogenase and aldehyde dehydrogenase participate in the oxidation of 20‐hydroxy‐LXB4 to 20‐carboxy‐LXB4.

Original languageEnglish
Pages (from-to)959-965
Number of pages7
JournalEuropean Journal of Biochemistry
Volume224
Issue number3
DOIs
Publication statusPublished - Jan 1 1994

Fingerprint

Metabolites
Liver
NAD
Rats
Aldehyde Dehydrogenase
Leukotrienes
Alcohol Dehydrogenase
NADP
Cytosol
Oxidation
Disulfiram
Hydroxylation
Leukotriene B4
Molecular oxygen
Liquid chromatography
Liver Microsomes
Carbon Monoxide
Microsomes
Liquid Chromatography
Gas chromatography

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

ω‐Oxidation of Lipoxin B4 by Rat Liver : Identification of an ω‐Carboxy Metabolite of Lipoxin B4. / Mizukami, Yoichi; Sumimoto, Hideki; Isobe, Ryuichi; Minakami, Shigeki; Takeshige, Koichiro.

In: European Journal of Biochemistry, Vol. 224, No. 3, 01.01.1994, p. 959-965.

Research output: Contribution to journalArticle

Mizukami, Yoichi ; Sumimoto, Hideki ; Isobe, Ryuichi ; Minakami, Shigeki ; Takeshige, Koichiro. / ω‐Oxidation of Lipoxin B4 by Rat Liver : Identification of an ω‐Carboxy Metabolite of Lipoxin B4. In: European Journal of Biochemistry. 1994 ; Vol. 224, No. 3. pp. 959-965.
@article{4c5c271a63ce46109a528e3caaeba017,
title = "ω‐Oxidation of Lipoxin B4 by Rat Liver: Identification of an ω‐Carboxy Metabolite of Lipoxin B4",
abstract = "Lipoxin B4 (LXB4) is metabolized to 20‐hydroxy‐LXB4 by rat liver microsomes. The ω‐hydroxylation requires both molecular oxygen and NADPH, and is inhibited by carbon monoxide, indicating involvement of a cytochrome P‐450 (P‐450). This is supported by inhibition of the reaction by antibodies raised against NADPH–P‐450 reductase. The P‐450 appears to be the one responsible for leukotriene B4ω‐hydroxylation, because leukotriene B4 inhibits the formation of 20‐hydroxy‐LXB4 and LXB4 blocks the leukotriene B4ω‐hydroxylase activity in microsomes. Incubation of 20‐hydroxy‐LXB4 with both rat liver cytosol and NAD+ leads to formation of a more polar metabolite on high‐performance liquid chromatography. The metabolite is identified as 20‐carboxy‐LXB4, a novel metabolite of LXB4, based on analyses by ultraviolet spectrometry and by gas chromatography/mass spectrometry. The 20‐carboxy‐LXB4‐forming activity is localized in cytosol, with an optimal pH of 8.5. The activity is dependent on NAD+, but NADP+ can not replace NAD+. The reaction is inhibited by pyrazole and 4‐methylpyrazole, inhibitors of alcohol dehydrogenase, and by substrates of the enzyme such as ethanol and 20‐hydroxy‐leukotriene B4. Disulfiram, an inhibitor of aldehyde dehydrogenase, also blocks the 20‐carboxy‐LXB4 formation. These observations suggest that both alcohol dehydrogenase and aldehyde dehydrogenase participate in the oxidation of 20‐hydroxy‐LXB4 to 20‐carboxy‐LXB4.",
author = "Yoichi Mizukami and Hideki Sumimoto and Ryuichi Isobe and Shigeki Minakami and Koichiro Takeshige",
year = "1994",
month = "1",
day = "1",
doi = "10.1111/j.1432-1033.1994.00959.x",
language = "English",
volume = "224",
pages = "959--965",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - ω‐Oxidation of Lipoxin B4 by Rat Liver

T2 - Identification of an ω‐Carboxy Metabolite of Lipoxin B4

AU - Mizukami, Yoichi

AU - Sumimoto, Hideki

AU - Isobe, Ryuichi

AU - Minakami, Shigeki

AU - Takeshige, Koichiro

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Lipoxin B4 (LXB4) is metabolized to 20‐hydroxy‐LXB4 by rat liver microsomes. The ω‐hydroxylation requires both molecular oxygen and NADPH, and is inhibited by carbon monoxide, indicating involvement of a cytochrome P‐450 (P‐450). This is supported by inhibition of the reaction by antibodies raised against NADPH–P‐450 reductase. The P‐450 appears to be the one responsible for leukotriene B4ω‐hydroxylation, because leukotriene B4 inhibits the formation of 20‐hydroxy‐LXB4 and LXB4 blocks the leukotriene B4ω‐hydroxylase activity in microsomes. Incubation of 20‐hydroxy‐LXB4 with both rat liver cytosol and NAD+ leads to formation of a more polar metabolite on high‐performance liquid chromatography. The metabolite is identified as 20‐carboxy‐LXB4, a novel metabolite of LXB4, based on analyses by ultraviolet spectrometry and by gas chromatography/mass spectrometry. The 20‐carboxy‐LXB4‐forming activity is localized in cytosol, with an optimal pH of 8.5. The activity is dependent on NAD+, but NADP+ can not replace NAD+. The reaction is inhibited by pyrazole and 4‐methylpyrazole, inhibitors of alcohol dehydrogenase, and by substrates of the enzyme such as ethanol and 20‐hydroxy‐leukotriene B4. Disulfiram, an inhibitor of aldehyde dehydrogenase, also blocks the 20‐carboxy‐LXB4 formation. These observations suggest that both alcohol dehydrogenase and aldehyde dehydrogenase participate in the oxidation of 20‐hydroxy‐LXB4 to 20‐carboxy‐LXB4.

AB - Lipoxin B4 (LXB4) is metabolized to 20‐hydroxy‐LXB4 by rat liver microsomes. The ω‐hydroxylation requires both molecular oxygen and NADPH, and is inhibited by carbon monoxide, indicating involvement of a cytochrome P‐450 (P‐450). This is supported by inhibition of the reaction by antibodies raised against NADPH–P‐450 reductase. The P‐450 appears to be the one responsible for leukotriene B4ω‐hydroxylation, because leukotriene B4 inhibits the formation of 20‐hydroxy‐LXB4 and LXB4 blocks the leukotriene B4ω‐hydroxylase activity in microsomes. Incubation of 20‐hydroxy‐LXB4 with both rat liver cytosol and NAD+ leads to formation of a more polar metabolite on high‐performance liquid chromatography. The metabolite is identified as 20‐carboxy‐LXB4, a novel metabolite of LXB4, based on analyses by ultraviolet spectrometry and by gas chromatography/mass spectrometry. The 20‐carboxy‐LXB4‐forming activity is localized in cytosol, with an optimal pH of 8.5. The activity is dependent on NAD+, but NADP+ can not replace NAD+. The reaction is inhibited by pyrazole and 4‐methylpyrazole, inhibitors of alcohol dehydrogenase, and by substrates of the enzyme such as ethanol and 20‐hydroxy‐leukotriene B4. Disulfiram, an inhibitor of aldehyde dehydrogenase, also blocks the 20‐carboxy‐LXB4 formation. These observations suggest that both alcohol dehydrogenase and aldehyde dehydrogenase participate in the oxidation of 20‐hydroxy‐LXB4 to 20‐carboxy‐LXB4.

UR - http://www.scopus.com/inward/record.url?scp=0028169966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028169966&partnerID=8YFLogxK

U2 - 10.1111/j.1432-1033.1994.00959.x

DO - 10.1111/j.1432-1033.1994.00959.x

M3 - Article

C2 - 7925420

AN - SCOPUS:0028169966

VL - 224

SP - 959

EP - 965

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 3

ER -